Mapping networks of alpha-Synuclein proteostasis in cellular models of Parkinson's disease pathology
Parkinson’s disease (PD) is the second most common neurodegenerative disorder for which there is no disease-modifying therapy. Pathologically, the neuronal loss correlates with abnormal accumulation, aggregation and toxic gain of function of the small pre-synaptic protein alpha-Synuclein (aSyn). Whe...
Main Author: | Lewin, R |
---|---|
Other Authors: | Tofaris, G |
Format: | Thesis |
Language: | English |
Published: |
2020
|
Subjects: |
Similar Items
-
Relationship of Apolipoprotein E to Parkinson's disease-related alpha-synuclein pathology
by: Parkkinen, L, et al.
Published: (2013) -
LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.
by: Alegre-Abarrategui, J, et al.
Published: (2008) -
Initiation and progression of α-synuclein pathology in Parkinson’s disease
by: Tofaris, GK
Published: (2022) -
Targeting alpha-synuclein as a therapy for Parkinson’s disease
by: Fields, CR, et al.
Published: (2019) -
Network pharmacology of the MPP+ cellular model of Parkinson’s disease
by: Keane, H
Published: (2015)